Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2001 Nov;60(11):996–1002. doi: 10.1136/ard.60.11.996

Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51

H Direskeneli 1
PMCID: PMC1753405  PMID: 11602462

Full Text

The Full Text of this article is available as a PDF (151.5 KB).

Figure 1  .

Figure 1  

Open in a new tab

Role of bacterial and human heat shock protein (HSP) 60/65 as T cell antigens in Behçet's disease. APC = antigen presenting cells.

Figure 2  .

Figure 2  

Open in a new tab

An immunological model for the role of cross reactive retinal-S antigen (S-Ag) and HLA-B27/51 derived peptides in chronic posterior uveitis of Behçet's disease.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bajramović J. J., Lassmann H., van Noort J. M. Expression of alphaB-crystallin in glia cells during lesional development in multiple sclerosis. J Neuroimmunol. 1997 Sep;78(1-2):143–151. doi: 10.1016/s0165-5728(97)00092-1. [DOI] [PubMed] [Google Scholar]
  2. Bauer S., Groh V., Wu J., Steinle A., Phillips J. H., Lanier L. L., Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 1999 Jul 30;285(5428):727–729. doi: 10.1126/science.285.5428.727. [DOI] [PubMed] [Google Scholar]
  3. Baum H., Davies H., Peakman M. Molecular mimicry in the MHC: hidden clues to autoimmunity? Immunol Today. 1996 Feb;17(2):64–70. doi: 10.1016/0167-5699(96)80581-0. [DOI] [PubMed] [Google Scholar]
  4. Bläss S., Engel J. M., Burmester G. R. The immunologic homunculus in rheumatoid arthritis. Arthritis Rheum. 1999 Dec;42(12):2499–2506. doi: 10.1002/1529-0131(199912)42:12<2499::AID-ANR1>3.0.CO;2-R. [DOI] [PubMed] [Google Scholar]
  5. Buyon J. P., Korchak H. M., Rutherford L. E., Ganguly M., Weissmann G. Female hormones reduce neutrophil responsiveness in vitro. Arthritis Rheum. 1984 Jun;27(6):623–630. doi: 10.1002/art.1780270604. [DOI] [PubMed] [Google Scholar]
  6. Calgüneri M., Kiraz S., Ertenli I., Benekli M., Karaarslan Y., Celik I. The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behçet's disease. A randomized clinical trial. Arthritis Rheum. 1996 Dec;39(12):2062–2065. doi: 10.1002/art.1780391216. [DOI] [PubMed] [Google Scholar]
  7. Carletto A., Pacor M. L., Biasi D., Caramaschi P., Zeminian S., Bellavite P., Bambara L. M. Changes of neutrophil migration without modification of in vitro metabolism and adhesion in Behçet's disease. J Rheumatol. 1997 Jul;24(7):1332–1336. [PubMed] [Google Scholar]
  8. Celet B., Akman-Demir G., Serdaroğlu P., Yentür S. P., Taşci B., van Noort J. M., Eraksoy M., Saruhan-Direskeneli G. Anti-alpha B-crystallin immunoreactivity in inflammatory nervous system diseases. J Neurol. 2000 Dec;247(12):935–939. doi: 10.1007/s004150070049. [DOI] [PubMed] [Google Scholar]
  9. Chambers J. C., Haskard D. O., Kooner J. S. Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome. J Am Coll Cardiol. 2001 Feb;37(2):517–520. doi: 10.1016/s0735-1097(00)01137-2. [DOI] [PubMed] [Google Scholar]
  10. Chicz R. M., Urban R. G., Gorga J. C., Vignali D. A., Lane W. S., Strominger J. L. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med. 1993 Jul 1;178(1):27–47. doi: 10.1084/jem.178.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Direskeneli H., Eksioglu-Demiralp E., Kibaroglu A., Yavuz S., Ergun T., Akoglu T. Oligoclonal T cell expansions in patients with Behçet's disease. Clin Exp Immunol. 1999 Jul;117(1):166–170. doi: 10.1046/j.1365-2249.1999.00931.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Direskeneli H., Ekşioglu-Demiralp E., Yavuz S., Ergun T., Shinnick T., Lehner T., Akoglu T. T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behçet's disease. J Rheumatol. 2000 Mar;27(3):708–713. [PubMed] [Google Scholar]
  13. Direskeneli H., Hasan A., Shinnick T., Mizushima R., van der Zee R., Fortune F., Stanford M. R., Lehner T. Recognition of B-cell epitopes of the 65 kDa HSP in Behçet's disease. Scand J Immunol. 1996 Apr;43(4):464–471. doi: 10.1046/j.1365-3083.1996.d01-53.x. [DOI] [PubMed] [Google Scholar]
  14. Direskeneli H., Keser G., D'Cruz D., Khamashta M. A., Akoğlu T., Yazici H., Yurdakul S., Hamuryudan V., Ozgün S., Goral A. J. Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behçet's disease. Clin Rheumatol. 1995 Jan;14(1):55–61. doi: 10.1007/BF02208085. [DOI] [PubMed] [Google Scholar]
  15. Ehrlich G. E. Behçet disease and the emergence of thalidomide. Ann Intern Med. 1998 Mar 15;128(6):494–495. doi: 10.7326/0003-4819-128-6-199803150-00011. [DOI] [PubMed] [Google Scholar]
  16. Ehrlich G. E. Vasculitis in Behçet's disease. Int Rev Immunol. 1997;14(1):81–88. doi: 10.3109/08830189709116846. [DOI] [PubMed] [Google Scholar]
  17. Ekşioglu-Demiralp E., Kibaroglu A., Direskeneli H., Yavuz S., Karsli F., Yurdakul S., Yazici H., Akoglu T. Phenotypic characteristics of B cells in Behçet's disease: increased activity in B cell subsets. J Rheumatol. 1999 Apr;26(4):826–832. [PubMed] [Google Scholar]
  18. Falk K., Rötzschke O., Takiguchi M., Gnau V., Stevanović S., Jung G., Rammensee H. G. Peptide motifs of HLA-B51, -B52 and -B78 molecules, and implications for Behćet's disease. Int Immunol. 1995 Feb;7(2):223–228. doi: 10.1093/intimm/7.2.223. [DOI] [PubMed] [Google Scholar]
  19. Frassanito M. A., Dammacco R., Cafforio P., Dammacco F. Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum. 1999 Sep;42(9):1967–1974. doi: 10.1002/1529-0131(199909)42:9<1967::AID-ANR24>3.0.CO;2-Z. [DOI] [PubMed] [Google Scholar]
  20. Freysdottir J., Lau S., Fortune F. Gammadelta T cells in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS). Clin Exp Immunol. 1999 Dec;118(3):451–457. doi: 10.1046/j.1365-2249.1999.01069.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Gül A., Aslantas A. B., Tekinay T., Koniçe M., Ozçelik T. Procoagulant mutations and venous thrombosis in Behçet's disease. Rheumatology (Oxford) 1999 Dec;38(12):1298–1299. doi: 10.1093/rheumatology/38.12.1298. [DOI] [PubMed] [Google Scholar]
  22. Gül A., Hajeer A. H., Worthington J., Barrett J. H., Ollier W. E., Silman A. J. Evidence for linkage of the HLA-B locus in Behçet's disease, obtained using the transmission disequilibrium test. Arthritis Rheum. 2001 Jan;44(1):239–240. doi: 10.1002/1529-0131(200101)44:1<239::AID-ANR31>3.0.CO;2-X. [DOI] [PubMed] [Google Scholar]
  23. Gül A., Inanç M., Ocal L., Aral O., Koniçe M. Familial aggregation of Behçet's disease in Turkey. Ann Rheum Dis. 2000 Aug;59(8):622–625. doi: 10.1136/ard.59.8.622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hallett M. B., Lloyds D. Neutrophil priming: the cellular signals that say 'amber' but not 'green'. Immunol Today. 1995 Jun;16(6):264–268. doi: 10.1016/0167-5699(95)80178-2. [DOI] [PubMed] [Google Scholar]
  25. Hamuryudan V., Mat C., Saip S., Ozyazgan Y., Siva A., Yurdakul S., Zwingenberger K., Yazici H. Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1998 Mar 15;128(6):443–450. doi: 10.7326/0003-4819-128-6-199803150-00004. [DOI] [PubMed] [Google Scholar]
  26. Hasan A., Fortune F., Wilson A., Warr K., Shinnick T., Mizushima Y., van der Zee R., Stanford M. R., Sanderson J., Lehner T. Role of gamma delta T cells in pathogenesis and diagnosis of Behcet's disease. Lancet. 1996 Mar 23;347(9004):789–794. doi: 10.1016/s0140-6736(96)90868-5. [DOI] [PubMed] [Google Scholar]
  27. Hirohata S., Oka H., Mizushima Y. Streptococcal-related antigens stimulate production of IL6 and interferon-gamma by T cells from patients with Behcet's disease. Cell Immunol. 1992 Apr;140(2):410–419. doi: 10.1016/0008-8749(92)90207-6. [DOI] [PubMed] [Google Scholar]
  28. Hu W., Hasan A., Wilson A., Stanford M. R., Li-Yang Y., Todryk S., Whiston R., Shinnick T., Mizushima Y., van der Zee R. Experimental mucosal induction of uveitis with the 60-kDa heat shock protein-derived peptide 336-351. Eur J Immunol. 1998 Aug;28(8):2444–2455. doi: 10.1002/(SICI)1521-4141(199808)28:08<2444::AID-IMMU2444>3.0.CO;2-N. [DOI] [PubMed] [Google Scholar]
  29. Kaneko S., Suzuki N., Yamashita N., Nagafuchi H., Nakajima T., Wakisaka S., Yamamoto S., Sakane T. Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behcet's disease (BD) in Japan. Clin Exp Immunol. 1997 May;108(2):204–212. doi: 10.1046/j.1365-2249.1997.3611265.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kurhan-Yavuz S., Direskeneli H., Bozkurt N., Ozyazgan Y., Bavbek T., Kazokoglu H., Eksioglu-Demiralp E., Wildner G., Diedrichs-Möhring M., Akoglu T. Anti-MHC autoimmunity in Behçet's disease: T cell responses to an HLA-B-derived peptide cross-reactive with retinal-S antigen in patients with uveitis. Clin Exp Immunol. 2000 Apr;120(1):162–166. doi: 10.1046/j.1365-2249.2000.01176.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Lamb J. R., Young D. B. T cell recognition of stress proteins. A link between infectious and autoimmune disease. Mol Biol Med. 1990 Aug;7(4):311–321. [PubMed] [Google Scholar]
  32. Lehner T., Lavery E., Smith R., van der Zee R., Mizushima Y., Shinnick T. Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Behçet's syndrome. Infect Immun. 1991 Apr;59(4):1434–1441. doi: 10.1128/iai.59.4.1434-1441.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lehner T. The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behçet's disease. Int Rev Immunol. 1997;14(1):21–32. doi: 10.3109/08830189709116842. [DOI] [PubMed] [Google Scholar]
  34. Mantaş C., Direskeneli H., Ekşioglu-Demiralp E., Akoglu T. Serum levels of Th2 cytokines IL-4 and IL-10 in Behçet's disease. J Rheumatol. 1999 Feb;26(2):510–512. [PubMed] [Google Scholar]
  35. Matsui T., Kurokawa M., Kobata T., Oki S., Azuma M., Tohma S., Inoue T., Yamamoto K., Nishioka K., Kato T. Autoantibodies to T cell costimulatory molecules in systemic autoimmune diseases. J Immunol. 1999 Apr 1;162(7):4328–4335. [PubMed] [Google Scholar]
  36. Mege J. L., Dilsen N., Sanguedolce V., Gul A., Bongrand P., Roux H., Ocal L., Inanç M., Capo C. Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol. 1993 Sep;20(9):1544–1549. [PubMed] [Google Scholar]
  37. Miyamoto N., Mandai M., Suzuma I., Suzuma K., Kobayashi K., Honda Y. Estrogen protects against cellular infiltration by reducing the expressions of E-selectin and IL-6 in endotoxin-induced uveitis. J Immunol. 1999 Jul 1;163(1):374–379. [PubMed] [Google Scholar]
  38. Mizuki N., Inoko H., Ohno S. Pathogenic gene responsible for the predisposition of Behçet's disease. Int Rev Immunol. 1997;14(1):33–48. doi: 10.3109/08830189709116843. [DOI] [PubMed] [Google Scholar]
  39. Mizuki N., Ohno S. Immunogenetic studies of Behçet's disease. Rev Rhum Engl Ed. 1996 Jul-Sep;63(7-8):520–527. [PubMed] [Google Scholar]
  40. Mizuki N., Ota M., Katsuyama Y., Yabuki K., Ando H., Goto K., Nakamura S., Bahram S., Ohno S., Inoko H. Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behçet's disease. Arthritis Rheum. 1999 Sep;42(9):1961–1966. doi: 10.1002/1529-0131(199909)42:9<1961::AID-ANR23>3.0.CO;2-7. [DOI] [PubMed] [Google Scholar]
  41. Mochizuki M., Suzuki N., Takeno M., Nagafuchi H., Harada T., Kaneoka H., Yamashita N., Hirayama K., Nakajima T., Mizushima Y. Fine antigen specificity of human gamma delta T cell lines (V gamma 9+) established by repetitive stimulation with a serotype (KTH-1) of a gram-positive bacterium, Streptococcus sanguis. Eur J Immunol. 1994 Jul;24(7):1536–1543. doi: 10.1002/eji.1830240712. [DOI] [PubMed] [Google Scholar]
  42. Nagvekar N., Jacobson L. W., Willcox N., Vincent A. Epitopes expressed in myasthenia gravis (MG) thymomas are not recognized by patients' T cells or autoantibodies. Clin Exp Immunol. 1998 Apr;112(1):17–20. doi: 10.1046/j.1365-2249.1998.00556.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Ohno S., Ohguchi M., Hirose S., Matsuda H., Wakisaka A., Aizawa M. Close association of HLA-Bw51 with Behçet's disease. Arch Ophthalmol. 1982 Sep;100(9):1455–1458. doi: 10.1001/archopht.1982.01030040433013. [DOI] [PubMed] [Google Scholar]
  44. Pervin K., Childerstone A., Shinnick T., Mizushima Y., van der Zee R., Hasan A., Vaughan R., Lehner T. T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease. J Immunol. 1993 Aug 15;151(4):2273–2282. [PubMed] [Google Scholar]
  45. Pronai L., Ichikawa Y., Nakazawa H., Arimori S. Enhanced superoxide generation and the decreased superoxide scavenging activity of peripheral blood leukocytes in Behçet's disease--effects of colchicine. Clin Exp Rheumatol. 1991 May-Jun;9(3):227–233. [PubMed] [Google Scholar]
  46. Raziuddin S., al-Dalaan A., Bahabri S., Siraj A. K., al-Sedairy S. Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern. J Rheumatol. 1998 Feb;25(2):329–333. [PubMed] [Google Scholar]
  47. SEZER F. N. The isolation of a virus as the cause of Behcet's diseases. Am J Ophthalmol. 1953 Mar;36(3):301–315. doi: 10.1016/0002-9394(53)91372-5. [DOI] [PubMed] [Google Scholar]
  48. Sahin S., Akoğlu T., Direskeneli H., Sen L. S., Lawrence R. Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behçet's disease. Ann Rheum Dis. 1996 Feb;55(2):128–133. doi: 10.1136/ard.55.2.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Sakane T., Takeno M., Suzuki N., Inaba G. Behçet's disease. N Engl J Med. 1999 Oct 21;341(17):1284–1291. doi: 10.1056/NEJM199910213411707. [DOI] [PubMed] [Google Scholar]
  50. Sohn S., Lee E. S., Kwon H. J., Lee S. I., Bang D., Lee S. Expression of Th2 cytokines decreases the development of and improves Behçet's disease-like symptoms induced by herpes simplex virus in mice. J Infect Dis. 2001 Mar 19;183(8):1180–1186. doi: 10.1086/319681. [DOI] [PubMed] [Google Scholar]
  51. Stanford M. R., Kasp E., Whiston R., Hasan A., Todryk S., Shinnick T., Mizushima Y., Dumonde D. C., van der Zee R., Lehner T. Heat shock protein peptides reactive in patients with Behçet's disease are uveitogenic in Lewis rats. Clin Exp Immunol. 1994 Aug;97(2):226–231. doi: 10.1111/j.1365-2249.1994.tb06072.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Sugi-Ikai N., Nakazawa M., Nakamura S., Ohno S., Minami M. Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet's disease. Invest Ophthalmol Vis Sci. 1998 May;39(6):996–1004. [PubMed] [Google Scholar]
  53. Suzuki N., Sakane T., Ueda Y., Tsunematsu T. Abnormal B cell function in patients with Behçet's disease. Arthritis Rheum. 1986 Feb;29(2):212–219. doi: 10.1002/art.1780290209. [DOI] [PubMed] [Google Scholar]
  54. Suzuki Y., Hoshi K., Matsuda T., Mizushima Y. Increased peripheral blood gamma delta+ T cells and natural killer cells in Behçet's disease. J Rheumatol. 1992 Apr;19(4):588–592. [PubMed] [Google Scholar]
  55. Takeno M., Kariyone A., Yamashita N., Takiguchi M., Mizushima Y., Kaneoka H., Sakane T. Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice. Arthritis Rheum. 1995 Mar;38(3):426–433. doi: 10.1002/art.1780380321. [DOI] [PubMed] [Google Scholar]
  56. Tanaka T., Yamakawa N., Koike N., Suzuki J., Mizuno F., Usui M. Behçet's disease and antibody titers to various heat-shock protein 60s. Ocul Immunol Inflamm. 1999 Jun;7(2):69–74. doi: 10.1076/ocii.7.2.69.4018. [DOI] [PubMed] [Google Scholar]
  57. Taşi B., Direskeneli H., Serdaroglu P., Akman-Demir G., Eraksoy M., Saruhan-Direskeneli G. Humoral immune response to mycobacterial heat shock protein (hsp)65 in the cerebrospinal fluid of neuro-Behçet patients. Clin Exp Immunol. 1998 Jul;113(1):100–104. doi: 10.1046/j.1365-2249.1998.00620.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Thurau S. R., Diedrichs-Möhring M., Fricke H., Burchardi C., Wildner G. Oral tolerance with an HLA-peptide mimicking retinal autoantigen as a treatment of autoimmune uveitis. Immunol Lett. 1999 Jun 1;68(2-3):205–212. doi: 10.1016/s0165-2478(99)00071-1. [DOI] [PubMed] [Google Scholar]
  59. Tokay S., Direskeneli H., Yurdakul S., Akoglu T. Anticardiolipin antibodies in Behçet's disease: a reassessment. Rheumatology (Oxford) 2001 Feb;40(2):192–195. doi: 10.1093/rheumatology/40.2.192. [DOI] [PubMed] [Google Scholar]
  60. Tüzün B., Tüzün Y., Yurdakul S., Hamuryudan V., Yazici H., Ozyazgan Y. Neutrophil chemotaxis in Behçet's syndrome. Ann Rheum Dis. 1999 Oct;58(10):658–658. doi: 10.1136/ard.58.10.658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Verity D. H., Marr J. E., Ohno S., Wallace G. R., Stanford M. R. Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens. 1999 Sep;54(3):213–220. doi: 10.1034/j.1399-0039.1999.540301.x. [DOI] [PubMed] [Google Scholar]
  62. Wildner G., Thurau S. R. Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease. Eur J Immunol. 1994 Nov;24(11):2579–2585. doi: 10.1002/eji.1830241103. [DOI] [PubMed] [Google Scholar]
  63. Yamamoto J. H., Minami M., Inaba G., Masuda K., Mochizuki M. Cellular autoimmunity to retinal specific antigens in patients with Behçet's disease. Br J Ophthalmol. 1993 Sep;77(9):584–589. doi: 10.1136/bjo.77.9.584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Yazici H., Akokan G., Yalçin B., Müftüoğlu A. The high prevalence of HLA-B5 in Behçet's disease. Clin Exp Immunol. 1977 Nov;30(2):259–261. [PMC free article] [PubMed] [Google Scholar]
  65. Yazici H., Başaran G., Hamuryudan V., Hizli N., Yurdakul S., Mat C., Tüzün Y., Ozyazgan Y., Dimitriyadis I. The ten-year mortality in Behçet's syndrome. Br J Rheumatol. 1996 Feb;35(2):139–141. doi: 10.1093/rheumatology/35.2.139. [DOI] [PubMed] [Google Scholar]
  66. Yazici H., Mat C., Deniz S., Iscimen A., Yurdakul S., Tuzun Y., Hekim N., Yazici Y. Sebum production is increased in Behçet's syndrome and even more so in rheumatoid arthritis. Clin Exp Rheumatol. 1987 Oct-Dec;5(4):371–374. [PubMed] [Google Scholar]
  67. Yazici H. The place of Behçet's syndrome among the autoimmune diseases. Int Rev Immunol. 1997;14(1):1–10. doi: 10.3109/08830189709116840. [DOI] [PubMed] [Google Scholar]
  68. Yurdakul S., Günaydin I., Tüzün Y., Tankurt N., Pazarli H., Ozyazgan Y., Yazici H. The prevalence of Behçet's syndrome in a rural area in northern Turkey. J Rheumatol. 1988;15(5):820–822. [PubMed] [Google Scholar]
  69. Zwirner N. W., Dole K., Stastny P. Differential surface expression of MICA by endothelial cells, fibroblasts, keratinocytes, and monocytes. Hum Immunol. 1999 Apr;60(4):323–330. doi: 10.1016/s0198-8859(98)00128-1. [DOI] [PubMed] [Google Scholar]
  70. de Graeff-Meeder E. R., van Eden W., Rijkers G. T., Prakken B. J., Kuis W., Voorhorst-Ogink M. M., van der Zee R., Schuurman H. J., Helders P. J., Zegers B. J. Juvenile chronic arthritis: T cell reactivity to human HSP60 in patients with a favorable course of arthritis. J Clin Invest. 1995 Mar;95(3):934–940. doi: 10.1172/JCI117801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. de Smet M. D., Yamamoto J. H., Mochizuki M., Gery I., Singh V. K., Shinohara T., Wiggert B., Chader G. J., Nussenblatt R. B. Cellular immune responses of patients with uveitis to retinal antigens and their fragments. Am J Ophthalmol. 1990 Aug 15;110(2):135–142. doi: 10.1016/s0002-9394(14)76981-8. [DOI] [PubMed] [Google Scholar]
  72. van Eden W., van der Zee R., Paul A. G., Prakken B. J., Wendling U., Anderton S. M., Wauben M. H. Do heat shock proteins control the balance of T-cell regulation in inflammatory diseases? Immunol Today. 1998 Jul;19(7):303–307. doi: 10.1016/s0167-5699(98)01283-3. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES